NASDAQ:TELO | Income Statement | Telomir Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$444,674.00$1.76M-$1.72M-$0.79-$0.7960,837,46060,837,460
2026-03-31$467,797.00$1.04M-$990,947.00-$0.03-$0.0334,380,97134,380,971
2025-12-31$1.3M$2.13M-$2.06M-$0.06-$0.06613,130613,130
2025-09-30$759,525.00$1.15M-$1.1M-$0.03-$0.0332,398,90632,398,906
2025-06-30$42,839.00$5.07M-$5.07M-$0.17-$0.1730,010,16530,010,165
2025-03-31$336,996.00$2.19M$2.19M-$2.18M-$0.07-$0.0729,762,67129,762,671
2024-12-31$269,083.00$2.91M-$2.9M-$0.10-$0.1040,51640,516
2024-09-30$627,434.00$6.01M$15,445.00-$5.99M-$0.20-$0.2029,609,81429,609,814
2024-06-30$594,801.00$1.47M-$1.39M$0.05$0.0529,609,81429,609,814
2024-03-31$804,023.00$1.92M$1.92M-$6.25M-$0.23-$0.2329,276,48129,276,481
2023-12-31$203,784.00$1.08M-$9.33M$0.62$0.62-69,120-69,120
2023-09-30$262,562.00$954,153.00-$757,173.00-$1.71M-$0.06-$0.0627,097,29427,097,294
2023-06-30$667,626.00$1.43M-$1.55M-$0.06-$0.0627,097,29427,097,294
2023-03-31$440,335.00$482,938.00-$482,938.00-$0.02-$0.0226,893,01426,893,014

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$2.44M$10.54M-$10.41M-$0.33-$0.3331,653,09431,653,094
2024-12-31$2.24M$12.24M-$16.53M-$0.56-$0.5629,539,21929,539,219
2023-12-31$1.57M$3.94M-$13.07M$0.48$0.4827,304,72427,304,724
2022-12-31$833,206.00$854,147.00-$854,147.00-$0.03-$0.0326,829,28426,829,284

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.